• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0029981912
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/27/2023
Event Type  Injury  
Event Description
It was reported that the stent dislodged requiring additional intervention.The target lesion, located in the moderately calcified ostial right coronary artery (rca), was pre dilated and a 4.00 x 8 mm synergy megatron was advanced.During attempted deployment, it was noticed that the stent had "slipped off" the delivery system and was "loose" on the guidewire.Implantation of the device was not possible and the dislodged stent was retrieved via snare.An additional synergy megatron was used to complete the procedure.No patient complications were reported.
 
Manufacturer Narrative
Video/media review by manufacturer: received to the complaint was a short video clip from the procedure.A review of the video available confirms the alleged stent dislodgement.The recording shows an undeployed stent sitting on a wire distally from the distal end of the guide catheter.In the following frame the stent is shown deployed (expanded) and located higher up than the delivery balloon at one side of the guide catheter.The balloon appears to have no contrast liquid inside it.
 
Event Description
It was reported that the stent dislodged requiring additional intervention.The target lesion, located in the moderately calcified ostial right coronary artery (rca), was pre dilated and a 4.00 x 8 mm synergy megatron was advanced.During attempted deployment, it was noticed that the stent had "slipped off" the delivery system and was "loose" on the guidewire.Implantation of the device was not possible and the dislodged stent was retrieved via snare.An additional synergy megatron was used to complete the procedure.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY MEGATRON
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18503048
MDR Text Key332780236
Report Number2124215-2024-00698
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot Number0029981912
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/02/2024
Initial Date FDA Received01/12/2024
Supplement Dates Manufacturer Received02/02/2024
Supplement Dates FDA Received02/23/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-